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ARTICLE
Mutation in TRMU Related to Transfer RNA Modiﬁcation
Modulates the Phenotypic Expression of the Deafness-Associated
Mitochondrial 12S Ribosomal RNA Mutations
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Jennifer Lynne Peters, Ronghua Li, Yaping Qian, Xinjian Wang, Ester Ballana, Mordechai Shohat,
Jianxin Lu, Xavier Estivill, Kimitsuna Watanabe, and Nathan Fischel-Ghodsian
The human mitochondrial 12S ribosomal RNA (rRNA) A1555G mutation has been associated with aminoglycoside-
induced and nonsyndromic deafness in many families worldwide. Our previous investigation revealed that the A1555G
mutation is a primary factor underlying the development of deafness but is not sufﬁcient to produce a deafness phenotype.
However, it has been proposed that nuclear-modiﬁer genes modulate the phenotypic manifestation of the A1555G
mutation. Here, we identiﬁed the nuclear-modiﬁer gene TRMU, which encodes a highly conserved mitochondrial protein
related to transfer RNA (tRNA) modiﬁcation. Genotyping analysis of TRMU in 613 subjects from 1 Arab-Israeli kindred,
210 European (Italian pedigrees and Spanish pedigrees) families, and 31 Chinese pedigrees carrying the A1555G or the
C1494T mutation revealed a missense mutation (G28T) altering an invariant amino acid residue (A10S) in the evolu-
tionarily conserved N-terminal region of the TRMU protein. Interestingly, all 18 Arab-Israeli/Italian-Spanish matrilineal
relatives carrying both the TRMU A10S and 12S rRNA A1555G mutations exhibited prelingual profound deafness. Func-
tional analysis showed that this mutation did not affect importation of TRMU precursors into mitochondria. However,
the homozygous A10S mutation leads to a marked failure in mitochondrial tRNA metabolisms, speciﬁcally reducing the
steady-state levels of mitochondrial tRNA. As a consequence, these defects contribute to the impairment ofmitochondrial-
protein synthesis. Resultant biochemical defects aggravate the mitochondrial dysfunction associated with the A1555G
mutation, exceeding the threshold for expressing the deafness phenotype. These ﬁndings indicate that the mutated
TRMU, acting as amodiﬁer factor,modulates the phenotypicmanifestation of the deafness-associated 12S rRNAmutations.
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Mutations in mtDNA have been found to be one of the
most important causes of sensorineural hearing loss.1–2 In
particular, the homoplasmic A1555G and C1494T muta-
tions in the highly conserved decoding site of the mito-
chondrial 12S rRNA (MIM 561000) have been associated
with both aminoglycoside-induced and nonsyndromic
deafness [MIM 580000) in many families worldwide.3–8
Matrilineal relatives within and among families carrying
the A1555G mutation exhibited a wide range of pene-
trance and expressivity, including severity and age at onset
of deafness.4–6 Functional characterization demonstrated
more-severe biochemical defects in the mutant lympho-
blastoid cell lines derived from symptomatic individuals
of an Arab-Israeli family carrying the A1555G mutation
than from those of cell lines derived from asymptomatic
individuals in the same family.9 However, under a con-
stant nuclear background, a nearly identical degree of mi-
tochondrial dysfunction was observed in cybrid cell lines
derived from symptomatic and asymptomatic individuals
from this family.10 These ﬁndings strongly indicate that
the A1555G mutation is a primary factor underlying the
development of deafness but is itself insufﬁcient to pro-
duce a deafness phenotype. Thus, other modiﬁer factors,
such as aminoglycosides or nuclear-modiﬁer genes, mod-
ulate the phenotypic manifestation of the A1555G or the
C1494T mutation.3,8–11 The product of nuclear-modiﬁer
gene(s), whichmay functionally interact with themutated
12S rRNA, inﬂuences the phenotypic manifestation of the
A1555G mutation by enhancing or suppressing the effect
of the mutation.9
Extensive genomewide linkage studies of Arab-Israeli and
European (Italian and Spanish) families revealed that the
phenotypic expression of the A1555G mutation is, in fact,
inﬂuenced by a complex inheritance of multiple nuclear-
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1 ACAGCGCAGAAGAAGAGCAGT ACTACACAGGTGGAGGGCGA 58 572
2 CTCAGGCACCAAGATGGAAAC GAGGCCTCTTGCAGTCTTCAG 56 492
3 CGTAGTGGCAGAGAATAACACC ACAGTTGTGACACCATCTCCAA 53 525
4 CAGAGTGCTAGGATTACAGGC GGCAGGGACACTGTTTACTAC 50 725
5 GAGTGTTGATGTCTGCCTCTGA CCTCAGCAAACTCCTCCATCT 53 453
6 and 7 TCTAAGGCTCTGGCATCGTGT GGACGACAGGAACTCTGGTCTAG 56 491
8 GATGTGCTCAGGTGCTTGGT GACCAGCATACAACTCAGCCTA 54 495
9 and 10 GTGTGCTGGTAGGACAGTTGTT GTGACACCAGAGTGGAAATCC 52 830
11 TCTCCTGTTCAGCAGCAGCA ACACAGGTCAGCATCGCAGG 56 858
encoded modiﬁer genes.12 Despite statistical support for
the linkages of several putative modiﬁer loci, including
one locus localized to chromosome 8p23.1,13,14 no muta-
tions in these modiﬁer genes have been identiﬁed. Thus,
the involvement of multiple factors and a relatively rare
disorder make it very difﬁcult to identify such nuclear-
modiﬁer genes by use of conventional genetic approaches,
such as genomewide linkage analysis. Recently, we pro-
posed an interesting model for nuclear-mtDNA interac-
tion for the phenotypic manifestation of the A1555G or
the C1494T mutation.15–17 In the yeast Saccharomyces cer-
evisiae, the mutant alleles of MTO1, MSS1, or MTO2 that
encode mitochondrial proteins manifest a respiratory-de-
ﬁcient phenotype only when coupled with the mitochon-
drial 15S rRNA C1409G mutation17–19 corresponding to
human 12S rRNA C1494T mutation.3,8 This strongly sug-
gests that Mss1p, Mto1p, or Mto2p affects the phenotypic
expression of the C1409G mutation, by functionally in-
teracting with the region of C1409G in mitochondrial 15S
rRNA. In Escherichia coli, the products of mnmE (homolog
of MSS1),20 gidA (homolog ofMTO1),21 and trmU (homolog
of MTO2)22 have been shown to be involved in the bio-
synthesis of the hypermodiﬁed nucleoside 5-methyl-ami-
nomethy-2-thio-uridine (mnm5s2U34).23 This modiﬁed nu-
cleotide, found in the wobble position of several bacterial
and human mitochondrial tRNAs (mt tRNAs) speciﬁc for
glutamate, lysine, and glutamine, has a pivotal role in the
structure and function of tRNAs, including structural sta-
bilization, aminoacylation, and codon recognition at the
decoding site of small rRNA.21,23,24
Of these, TRMU has been shown to be responsible for the
2-thiolation ofmnm5s2U34 in tRNALys, tRNAGlu, and tRNAGln
in bacteria,22,25 yeast, and human mitochondria.24 Recently,
we demonstrated that isolated human TRMU cDNA can
complement the respiratory-deﬁcient phenotype of yeast
mto2 cells carrying the 15S rRNA C1409G mutation.17
Furthermore, we showed that, in families carrying the
A1555G mutation, there was highly suggestive linkage and
linkage disequilibrium between microsatellite markers ad-
jacent to TRMU and the presence of deafness.26 These ﬁnd-
ings strongly suggest that TRMU is a candidate nuclear-
modiﬁer gene for the phenotypic manifestation of the
deafness-associated 12S rRNA A1555G or C1494T muta-
tion. To assess the contribution that allelic variant(s) in
this gene makes toward the phenotypic expression of the
A1555G mutation, we performed mutational analysis of
TRMU in 613 subjects with nonsyndromic deafness from
1 Arab-Israeli kindred, 210 European families, and 31 Chi-
nese pedigrees. Functional signiﬁcance of the TRMU allelic
variant has been evaluated by examination of import and
processing of TRMU, mt tRNA modiﬁcation and stability,
and protein synthesis, through use of lymphoblastoid
mutant cell lines derived from Arab-Israeli controls and




DNA samples used for this investigation were from members of
families who carried the mtDNA A1555Gmutation and exhibited
nonsyndromic hearing loss: 67 members of a large Arab-Israeli
kindred,12 100 hearing-impaired members of 30 Chinese pedi-
grees,5,6,27 and 420 deaf individuals from 210 pedigrees of Italian-
Spanish background.14,28 In addition, DNA samples from 26 hear-
ing-impaired members of a large Chinese family carrying the
mtDNA C1494T mutation8 were also used for the mutation anal-
ysis. The control DNA samples were obtained from the following
panels: 137 individuals of Jewish background with normal hear-
ing, 100 hearing-impaired white subjects lacking the mtDNA
A1555G mutation, and 142 unaffected individuals of Han Chi-
nese ancestry. Informed consent, blood samples, and clinical eval-
uations were obtained from all participating familymembers, un-
der protocols approved by the Institutional Review Board of the
Cincinnati Children’s Hospital Medical Center.
Cell Lines and Culture Conditions
Human cell lines 143BTK and HeLa were used for the extraction
of RNA,mitochondrial protein import, and in vivomitochondrial
protein–labeling experiments. Both 143BTK and HeLa cells were
grown in regular Dulbecco’s modiﬁed Eagle medium (DMEM)
(Invitrogen) supplemented with 10% fetal bovine serum (FBS).
Six human immortalized lymphoblastoid cell lines derived from
members of the Arab-Israeli family (V-4, V-8, IV-5, IV-9, V-1, and
V-3) and two genetically unrelated Arab-Israeli control individuals
(#2 and #3)12 were grown in RPMI1640 medium (Invitrogen) sup-
plemented with 10% FBS.
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Figure 1. Mutation analysis of TRMU. A, Partial sequence chromatograms of TRMU from affected individual V-3 and normal-hearing
individual V-4 of the Arab-Israeli family11 and control #3. The arrow indicates the location of the nucleotide changes at position 28.
B, RFLP PCR for the G28T mutation in several members of the Arab-Israeli family. C, Sequence alignment of the N-terminal sequence
of human TRMU with its homologs. The arrow indicates the position of the A10S mutation.
Mutational Analysis of the TRMU Gene
Nine pairs of primers for PCR-amplifying exons and their ﬂanking
sequences, including splicing-donor and acceptor-consensus se-
quences of TRMU, were used for this analysis. The forward and
reverse primers for PCR ampliﬁcation and sequence analysis are
shown in table 1.
Fragments spanning 11 exons and ﬂanking sequences from 15
matrilineal relatives of this Arab-Israeli family,12 one spouse, and
two unrelated controls were PCR ampliﬁed, puriﬁed, and subse-
quently analyzed by direct sequencing in an ABI 3700 automated
DNA sequencer with use of the Big Dye Terminator Cycle se-
quencing reaction kit (Applied Biosystems). These sequence re-
sults were compared with the TRMU genomic sequence (GenBank
accession number AF448221).26 Genotyping for the G28T variant
in other subjects was PCR ampliﬁed for exon 1 and was followed
by digestion of the 467-bp segment with the restriction enzyme
Bsp1286I. The forward and reverse primers for exon 1 are 5′-
ACAGCGCAGAAGAAGAGCAGT-3′ and 5′-ACAACGCCACGAC-
GGACG-3′, respectively. The Bsp1286I-digested products were an-
alyzed on 1.5% agarose gels.
Mitochondrial Import Experiment
pGEM7-TRMU and pGEM7-TRMU-A10S were constructed by
inserting full-length wild-type and A10S mutant cDNA into
pGEM7Zf() (Promega).17 TRMU andmTERF precursorswere syn-
thesized in vitro with use of the TNT-coupled reticulocyte lysate
system (Promega) and pGEM7-TRMU, pGEM7-TRMU-Ser10, and
pmTERF29 constructs in the presence of [35S]methionine. Mito-
chondrial fractions were isolated from HeLa cells as described
elsewhere,30 were washed twice with an incubation buffer (10mM
Tris-HCl, 25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 10 mM
KH2PO4, 0.05 mM EDTA, and 5 mM MgCl2 [pH 7.4] at 25C), and
were resuspended in the incubation buffer containing 1 mg/ml
BSA, 2 mM Na succinate, 1 mM ATP, and 1 mM methionine. Then,
10 ml reticulocyte-lysate synthesized protein was added to 90 ml
of mitochondrial suspension, and the reactions were incubated
at 37C for 30 min. Mitochondria were washed twice with ice-
chilled incubation buffer, and the ﬁnal pellets were lysed with
twice-concentrated gel sample buffer. In some experiments, 10 mM
uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP),
0.5 mg/ml valinomccycin, and 20 mg/ml oligomycin were added
to the reaction 5 min before the import initiation, to dissipate
the electrochemical potential (DW). In other assays, mitochon-
dria, after the import incubation, were treated with 100 mg/ml
proteinase K in the incubation buffer for 15 min at room tem-
perature, followed by the addition of 0.5 mM phenylmethyl-
sulfonyl ﬂuoride, and were washed once in incubation buffer.
Mitochondrial lysates were analyzed by SDS-PAGE, as described
elsewhere.29
APM Gel Electrophoresis to Quantify 2-Thiouridine
Modiﬁcation in tRNAs
Total RNA samples from the lymphoblastoid cell lines ( )81# 10
were obtained by use of TRIzol reagent (Invitrogen). mt tRNALys,
tRNAGlu, and tRNAGln were speciﬁcally labeled with 32P at the 3′
termini, following the method described elsewhere.31 Oligonu-
cleotide probes are as follows: 5′-GTGGTCACTGTAAAGAGGT-
GTTG-3′ (tRNALys), 5′-GTGGTATTCTCGCACGGACTACAACC-3′
(tRNAGlu), and 5′-GTGGCTAGGACTATGAGAATCGAACC-3′ (t-
RNAGln). (N-acryloylamino)phenyl mercuric chloride (APM) gel
electrophoresis and quantiﬁcation of 2-thiouridine modiﬁcation
in tRNAs were conducted as detailed elsewhere.32–33
mt tRNA Analysis
Total mtRNA preparations were obtained by using TOTALLY RNA
(Ambion) from mitochondria isolated from lymphobloid cell
lines (∼ cells), as described elsewhere.30 Five mg of total74.0# 10
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Figure 2. Eight pedigrees with nonsyndromic deafness. The TRMU G28T mutation was initially identiﬁed, by direct sequencing of PCR
fragments spanning coding regions, with use of genomic DNA derived from members of an Arab-Israeli kindred as template and
subsequently screened by RFLP PCR. Members marked with an asterisk (*) were examined for the TRMU mutation by direct sequencing
of PCR fragments spanning coding regions. Hearing-impaired individuals are indicated by blackened symbols. Individuals who harbored
homozygous (/), heterozygous (/), or wild type (/) mutations are indicated.
mitochondrial RNA was electrophoresed through a 10% poly-
acrylamide/7 M urea gel in Tris-borate-EDTA buffer (TBE) (after
heating the sample at 65C for 10 min) and then was electro-
blotted onto a positively charged nylon membrane (Roche) for
the hybridization analysis with speciﬁc oligodeoxynucleotide
probes. For the detection of tRNASer(UCN), tRNALeu(UUR), tRNALys,
tRNAMet, tRNAHis, tRNAGlu, 12S rRNA, and 5S RNA, the following
nonradioactive digoxigenin (DIG)-labeled oligodeoxynucleotides
speciﬁc for each RNA were used: 5′-CAAGCCAACCCCATGGC-
CTC-3′ (tRNASer[UCN]), 5′-GGTAAATAAGGGGTCGTAAGC-3′ (t-
RNAHis), 5′-TCACTGTAAAGAGGTGTTGG-3′ (tRNALys), 5′-TGTTA-
AGAAGAGGAATTGAA-3′ (tRNALeu[UUR]), 5′-TATTCTCGCACGGA-
CTACAA-3′ (tRNAGlu), 5′-TAGTACGGGAAGGGTATAACC-3′ (t-
RNAMet), 5′-GAAAGGCTAGGACCAAACCTA-3′ (12S rRNA),34 and
5′-GGGTGGTATGGCCGTAGAC-3′ (5S RNA).35 DIG-labeled oli-
godeoxynucleotides were generated by using DIG Oligonucleo-
tide Tailing Kit (Roche). The hybridization was performed as de-
tailed elsewhere.36 Quantiﬁcation of density in each band was
made as detailed elsewhere.36,37
Analysis of Mitochondrial-Protein Synthesis
Pulse labeling of the cell lines for 30 min with [35S]methionine-
[35S]cysteine in methionine-free DMEM in the presence of eme-
tine, electrophoretic analysis of the translation products, and
quantiﬁcation of radioactivity in the whole electrophoretic pat-
terns or in individual well-resolved bands was performed as de-
tailed elsewhere.9,38
Computer Analysis
Statistical analysis was performed by the unpaired, two-tailed Stu-
dent’s t-test contained in the Microsoft Excel program for Mac-
intosh (v. 5). Correlation analysis was performed using the curve
ﬁtting in the CA-Cricket Graph III program for Macintosh (v.
1.5.2).
Results
Mutation Screening of TRMU in Families
with Nonsyndromic Deafness
To determine whether TRMU modulates the phenotypic
expression of the A1555G or the C1494T mutation, we
performed a genotyping analysis of TRMU, using DNA
samples derived from three cohorts of subjects carrying
the A1555G or the C1494T mutation: (1) 67 members of
a large Arab-Israeli kindred,12 (2) 420 hearing-impaired sub-
jects from 210 European pedigrees,13,14,28 and (3) 126 hear-
ing-impaired members of 31 Chinese families.5,6,8,27 No sub-
jects had a history of exposure to aminoglycosides. First,
we performed the PCR-ampliﬁcation and sequence anal-
ysis of DNA fragments spanning exons and their ﬂanking
sequences of TRMU from 15 matrilineal relatives of a large
Arab-Israeli family, one spouse, and two unrelated control
individuals with normal hearing who were of Arab de-
scent.12 In this family, most hearing-impaired matrilineal
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Figure 3. Import into mitochondria and processing of human TRMU precursor. SDS-PAGE analysis of the in vitro transcribed/translated
products synthesized in the presence of [35S]methionine, with use of cDNA carrying human wild-type and mutant (A10S) TRMU or mTERF
as template, analyzed directly or after incubation with isolated HeLa cell mitochondria for 30 min at 37C under various conditions,
detailed in the “Material and Methods” section.
relatives exhibited congenital severe-to-profound hearing
loss, a few showed late-onset and/or mild-to-moderate
hearing impairment, and other matrilineal relatives had
normal hearing. This analysis identiﬁed a GrT transver-
sion at position 28 (G28T) (ﬁg. 1A) in exon 1 of some in-
dividuals, which caused an alaninerserine replacement
(A10S) at position 10. No other sequence changes in this
gene were identiﬁed among these individuals. As shown
in ﬁgure 1B, the A10 at the N-terminal sequence of this
polypeptide is a highly conserved residue, indicating that
this alanine might be important for the function of this
protein.
We further analyzed the presence of the G28Tmutation
in other subjects, by RFLP analysis, since the G28T mu-
tation creates a Bsp1286I site, as shown in ﬁgure 1C. In
the Arab-Israeli family, as shown in ﬁgure 2, three of the
deaf children (V-1, V-2, V-3) of asymptomatic mother IV-
2 (who harbors the heterozygous G28T mutation) carry
the homozygous G28Tmutation,whereas their asymptom-
atic sibling (V-4) is heterozygous for the G28T mutation.
Of other symptomatic members, 12 individuals are het-
erozygous for the G28T mutation, whereas 29 members
lack this mutation. Of 18 asymptomatic individuals, 10
are heterozygous for the TRMU G28T mutation, whereas
8 do not carry this mutation. However, theG28Tmutation
was absent in the 126 hearing-impaired Chinese subjects
of 31 pedigrees carrying either the A1555G or the C1494T
mutation. Of 420 hearing-impaired subjects of 210 Italian-
Spanish pedigrees, 15 subjects—who belong to 1 Italian
pedigree and 6 Spanish pedigrees, as shown in ﬁgure 2—
were homozygous for the G28T mutation. Interestingly,
all 15 subjects exhibited prelingual profound hearing loss.
Of other Italian-Spanish subjects, 73 were heterozygous
for the G28T mutation, and the others lacked this muta-
tion. These data indicate that other putativemodiﬁer genes
may contribute to the phenotypic manifestation of the
A1555G mutation in those hearing-impaired individuals.
Finally, we screened for the presence of this mutation
in 137 Jewish controls, 142 Chinese controls, and 100 deaf
whites without the A1555G mutation. The heterozygous
G28Tmutation was not detected in these Chinese controls
but was present in 14 Jewish controls and 12 deaf whites.
However, we did not identify the homozygous G28T mu-
tation in these control populations. This translates to∼10%
frequency of this variant in the Jewish and deaf white
populations. However, the allele frequency of this vari-
ant was ∼25% in both the Arab-Israeli family and the
420 hearing-impaired subjects of 210 Italian-Spanish ped-
igrees. The higher incidence of thisTRMU variant indicates
that this variant may be involved in deafness expression
in these subjects carrying the A1555G mutation.
Import and Processing of the Human TRMU Precursor Not
Affected by the A10S Mutation
To examine whether the A10S mutation affects TRMU im-
port, import/processing reactions were performed in which
the wild-type or mutant TRMU or mTERF putative pre-
cursors were labeled in vitro with an amino acid and then
were incubated with isolated HeLa cell mitochondria
under various conditions. As shown in ﬁgure 3, both
[35S]methionine-labeled precursors synthesized fromwild-
type and mutant TRMU constructs, after incubation with
mitochondria, produced only one band with the same
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electrophoretic mobility as did in vitro–synthesized pre-
cursors. By contrast, [35S]methionine-labeled precursors of
mTERF that contains cleavable mitochondrial targeting
presequence yielded, after incubation with the mitochon-
dria, two bands that corresponded to themTERF precursor
and 34-kDa mature forms.29 After the [35S]methionine-la-
beled precursors were incubated with mitochondria and
then were digested with proteinase K, only the 34-kDa
mature form and not the precursor of mTERF appeared,
whereas there was one band showing the same size as the
precursors of wild-type and mutant TRMU. In fact, the
imported polypeptides were resistant to proteinase K di-
gestion, whereas nonimported polypeptideswere sensitive
to proteinase K digestion. In the presence of uncoupler
CCCP to block the DW necessary for mitochondrial-pro-
tein import, all [35S]methionine-labeled polypeptideswere
unable to import into mitochondria; thus, they digested
completely with proteinase K. Those results clearly indi-
cated that both wild-type and mutant TRMU were im-
ported into mitochondria but, unlike the majority of nu-
cleus-encoded mitochondrial proteins such as mTERF,29
were not processed after import. Most importantly, efﬁ-
ciencies of the import of wild-type and A10S TRMU into
mitochondria are 38.4% and 36.7%, respectively. Thus,
there is no obvious difference, in terms of imported efﬁ-
ciency, between wild-type and mutant TRMU. This result
strongly indicated that the A10S mutation does not affect
TRMU import into mitochondria.
Defect in 2-Thiouridine Modiﬁcation at Position 34
in mt tRNALys, tRNAGlu, and tRNAGln Caused by the A10S
Mutation
To investigate whether the A10S mutation alters 2-thiour-
idinemodiﬁcation at position 34 inmt tRNAs, the 2-thiour-
idylation levels of tRNAs were determined by isolating total
RNA from eight lymphoblastoid cell lines, purifying mt
tRNAs, qualifying the 2-thiouridine modiﬁcation by the re-
tardation of electrophoresis mobility in polyacrylamide gel
containing 0.05 mg/ml APM,32–33 and hybridizing speciﬁc
probes for tRNALys, tRNAGlu, and tRNAGln. In this system, the
mercuric compound can speciﬁcally interact with the
tRNAs containing the thiocarbonyl group—such as tRNALys,
tRNAGlu, and tRNAGln—thereby retarding tRNA migration.
As can be seen in ﬁgure 4, the 2-thiouridylation levels
of tRNALys, tRNAGlu, and tRNAGln were reduced signiﬁcantly
in mutant cells carrying the A1555G and the homozygous
A10S mutations, compared with control cells. In particu-
lar, decreases of 35% and 16% of 2-thiouridylation and
tRNALys, respectively, were observed in mutant cells car-
rying the homozygous and heterozygous A10S mutation,
in comparison with wild-type cells. Furthermore, reduc-
tions of ∼13% and ∼6% in 2-thiouridylation of tRNAGlu
were found in mutant cells carrying the A1555Gmutation
and the homozygous or heterozygous A10S mutation, re-
spectively, as compared with that of wild-type cells. Sim-
ilarly, a reduction of ∼13% of 2-thiouridylation of tRNAGln
was observed in mutant cells carrying the A10S mutation
(both homozygous and heterozygous), as compared with
wild-type cells. As expected, the levels of 2-thiouridylation
of tRNALys, tRNAGlu, and tRNAGln in mutant cells carrying
the A1555G mutation but lacking the A10S mutation are
comparable with those in controls. These data strongly sug-
gest that the A10S mutation leads to defects in 2-thiouri-
dylation of mt tRNALys, tRNAGlu, and tRNAGln.
A10S Mutation Leads to a Decrease of Steady-State Level
of mt tRNAs
As illustrated in ﬁgure 5A, the amounts of tRNALys, tRNAGlu,
tRNALeu(UUR), tRNASer(UCN), tRNAMet, and tRNAHis were mark-
edly decreased in mutant cells carrying both the A1555G
and the homozygous TRMU A10S mutations, compared
with control cells. For comparison, the average levels of
each tRNA in the various control cell lines or mutant cell
lines were then normalized to the average levels in the
same cell lines for the reference 5S RNA, a nuclear-encoded
mitochondrial small RNA.35 As shown in ﬁgure 5B, the av-
erage steady-state levels of those tRNAs were signiﬁcantly
decreased in the mutant cell lines carrying both A1555G
and homozygous A10S mutations, relative to the controls
( ). In particular, the average levels of tRNAsPp .0037–.0099
in those mutant cells are 50% in the tRNALys, 75% in t-
RNAGlu, 34% in the tRNALeu(UUR), 60% in tRNASer(UCN), 40%
in tRNAHis, and 53% in tRNAMet of control levels. Strikingly,
the variations in the steady-state level of tRNALys and t-
RNAGlu among the individual control and mutant cells
carrying the A1555G and the homozygous A10S muta-
tions were correlated with the levels of 2-thiouridylation
of tRNALys ( ; ) and tRNAGlu ( ;rp 0.96 P ! .001 rp 0.97 P !
). However, there is no signiﬁcant reduction in the.001
average levels of mt tRNAs in mutant cells carrying both
A1555G and heterozygous A10Smutations relative to con-
trols ( ): 78% in the tRNALys, 88% in thePp .0674–.3673
tRNAGlu, 84% in the tRNALeu(UUR), 82% in the tRNASer(UCN),
86% in the tRNAHis, and 85% in the tRNAMet of control
levels. Furthermore, the average levels of those tRNAs in
mutant cell lines carrying the A1555G mutation but lack-
ing A10S mutation were comparable to those of control
cell lines. In addition, the average levels of each tRNA in
the various control cell lines or mutant cell lines were also
normalized to the average levels in the same cell lines for
the mitochondrial 12S rRNA.9 In fact, the reduction in the
average steady-state levels of those tRNAs in the mutant
cell lines carrying both A1555G and homozygous A10S
mutations relative to the controls were comparable with
those detected using 5S RNA as reference marker (data not
shown). These data indicate that the homozygous A10S
mutation leads to a defect in mt tRNA metabolism, thus
causing a marked reduction in the steady-state level of mt
tRNAs.
Mitochondrial-Protein Synthesis Defect
in the Lymphoblastoid Cell Lines
Figure 6A shows typical electrophoretic patterns of the or-
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Figure 4. Quantiﬁcation of 2-thiouridine modiﬁcation in mt tRNALys, tRNAGlu, and tRNAGln. A, The 3′ end-labeled mt tRNALys from each
lymphoblastoid cell line, analyzed by 10% polyacrylamide gel electrophoresis with () or without () APM. The retarded bands of 2-
thiolated tRNAs and nonretarded bands of tRNA without thiolation are marked with arrows. B, The 3′ end-labeled mt tRNALys, tRNAGlu,
and tRNAGln from mutant lymphoblastoid cell lines carrying the A10S mutation, analyzed by 10% polyacrylamide gel electrophoresis
with () or without () APM. C, Proportion in vivo of the 2-thiouridine modiﬁcation levels of mt tRNAs. The calculations were based
on three independent determinations of each mt tRNA in each cell line. The error bars indicate 2 SEMs; P indicates the signiﬁcance,
according to Student’s t test, of the difference between mutant and control values for each mt tRNA.
ganelle-speciﬁc translation products of themutant andcon-
trol lymphoblastoid cell lines. The patterns of themtDNA-
encoded polypeptides of the mutation-carrying lympho-
blastoid cell lines were qualitatively identical, in terms of
electrophoretic mobility of the various polypeptides, to
those of two control lymphoblastoid cell lines and of
143B.TK (ﬁg. 6A). However, the lymphoblastoid cell lines
carrying the mutations showed a clear tendency toward
decrease in the total rate of labeling of mitochondrial
translation products relative to control cell lines. Figure
6B illustrates a quantiﬁcation of the results of a large num-
ber of labeling experiments and electrophoretic runs,
which was performed by densitometric analysis of appro-
priate exposures of the ﬂuorograms and normalization to
the data obtained for the 143B.TK sample included in
each gel. In particular, the decrease in the rate of mito-
chondrial-protein labeling in cell lines V-1 and V-3, car-
rying both A1555G and homozygous A10S mutations,
relative to the controls had a range of 44%–57%, with an
average of 51%. Furthermore, the rate of mitochondrial-
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Figure 5. A, Northern-blot analysis of mt tRNA. Equal amounts (5 mg) of total mtRNA samples from the various cell lines were
electrophoresed through a denaturing polyacrylamide gel, were electroblotted, and were hybridized with DIG-labeled oligonucleotide
probes speciﬁc for the mt tRNALys, tRNAGlu, tRNALeu(UUR), tRNASer(UCN), tRNAHis, and tRNAMet; the blots were then stripped and rehybridized
with DIG-labeled 5S rRNA probe as a control. B, Quantiﬁcation of the levels of mt tRNA. Average relative tRNALys, tRNAGlu, tRNALeu(UUR),
tRNASer(UCN), tRNAHis, and tRNAMet content per cell, was normalized to the average content per cell of 5S RNA in the two control cell lines
and in the six mutant cell lines. The values for the latter are expressed as percentages of the average values for the control cell lines.
The calculations were based on three independent determinations of each mt tRNA in each cell line. The error bars indicate 2 SEMs; P
indicates the signiﬁcance, according to Student’s t test, of the difference between mutant and control values for each mt tRNA.
protein labeling in cell line V-4, which carried both
A1555G and heterozygous A10S mutations, revealed a
mild reduction (81%) relative to controls. Moreover, the
rate of mitochondrial-protein labeling in mutant cell line
IV-9, carrying only A1555G mutation but lacking A10S
mutation, was 87% of control cell lines. These data clearly
indicate that the homozygous A10S mutation leads to a
defect in mitochondrial-protein labeling.
Discussion
In this study, we identiﬁed and characterized the nuclear-
modiﬁer gene TRMU for the phenotypic expression of
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Figure 6. Mitochondrial protein–labeling analysis. A, Electrophoretic patterns of the mitochondrial translation products. The lympho-
blastoid cell lines and of 143B.TK cells were labeled for 30 min with [35S]methionine in the presence of 100 mg of emetine per ml,
an inhibitor for cytosolic protein synthesis. Samples containing equal amounts of protein (30 mg) were run in SDS/polyacrylamide
gradient gels. COI, COII, and COIII, subunits I, II, and III of cytochrome c oxidase; ND1, ND2, ND3, ND4, ND4L, ND5, and ND6, subunits
1, 2, 3, 4, 4L, 5, and 6 of the respiratory-chain NADH dehydrogenase; A6 and A8, subunits 6 and 8 of the H-ATPase; CYTb, apocytochrome
b. B, Quantiﬁcation of the rates of labeling of the mitochondrial translation products in lymphoblastoid cell lines. The rates of
mitochondrial-protein labeling, determined as described elsewhere,9 are expressed as percentages of the value for 143B.TK in each
gel, with error bars indicating 2 SEMs. Three independent labeling experiments and three or four electrophoretic analyses of each labeled
preparation were performed on each lymphoblastoid cell line. The horizontal dashed lines represent the average value for each group.
P indicates the signiﬁcance, according to Student’s t test, of the difference between mutant and control values for each mt tRNA.
deafness-associated mitochondrial 12S rRNA mutations.
In fact, TRMU encodes a highly conserved 5-methylam-
inomethyl-2-thiouridylate-methyltransferase responsible
for the biosynthesis of 5-taurinomethyl-2-thiouridine
(tm5s2U) of mt tRNALys, tRNAGlu, and tRNAGln in the
wobble position.24,39 The tm5s2U is further modiﬁed to
mnm5s2U34 in the same position of those tRNAs in E. coli
and human mitochondria.24,40 This modiﬁed nucleotide
contributes to the high ﬁdelity of codon recognition and
the structural formation and stabilization of functional
tRNAs.23 We showed that isolated human TRMU cDNA
partially restored the respiratory-deﬁcient phenotype of
yeast Mto2 cells carrying the C1409G mutation,17 and
there was highly suggestive linkage and linkage disequi-
librium between microsatellite markers adjacent to TRMU
and the presence of deafness.26 This led us to test whether
TRMU acts as a modiﬁer gene that modulates the phe-
notypic expression of the deafness-associated A1555G or
C1494T mutation in mitochondrial 12S rRNA.
Mutation analysis identiﬁed a single missense mutation
(A10S) in TRMU in some members of the Arab-Israeli fam-
ily and other European families. The A10S mutation lo-
cates at the evolutionarily conserved N-terminal region of
the TRMU protein. This mutation occurs in 10% of Jew-
ish and white populations lacking the A1555G mutation,
whereas the frequency of this variant was ∼25% in both
the Arab-Israeli and the European cohorts carrying the
A1555G mutation but not in either the deaf or normal-
hearing Chinese cohorts. These ﬁndings imply that the
A10S mutation, even in a homozygous form, is not suf-
ﬁcient to cause a clinical phenotype. However, all 18 ma-
trilineal relatives carrying both the homozygous TRMU
A10S and mtDNA A1555G mutations exhibited prelingual
profound deafness. This strongly indicates that the co-
existence of the homozygous TRMU A10S variant with the
12S rRNA A1555G mutation led to the expression of deaf-
ness in these subjects. However, the observation that other
symptomatic individuals in these families carried hetero-
zygous A10S mutation or lacked this mutation suggests
that other putative modiﬁer genes may contribute to the
phenotypic manifestation of the A1555G mutation. In
these cases, the deafness phenotype caused by the inter-
action between the TRMU A10S mutation and mtDNA
A1555G mutation did not have a signiﬁcant linkage and
did not well ﬁt the typical correlation of genotype and
phenotype caused by a disease with the single-gene in-
heritance. Therefore, strong functional evidences are nec-
essary for understanding the pathogenesis of diseases with
a complex inheritance of multiple factors.
The A10S mutation, despite localizing at the putative
mitochondrial targeting sequence,26 does not affect the
import of this human TRMU protein into mitochondria
but led to an alteration of TRMU enzymatic function. In-
deed, the homozygous A10S mutation caused a signiﬁcant
defect in 2-thio modiﬁcation in the wobble position of
mt tRNALys, tRNAGlu, and tRNAGln. These ﬁndings are con-
sistent with the fact that the small interfering RNA down-
regulation of human TRMU led to the defect in 2-thiour-
idylation24 in mt tRNALys, tRNAGlu, and tRNAGln. A failure
in 2-thio modiﬁcation likely results in a large proportion
of unmodiﬁed mt tRNAs. Those unmodiﬁed tRNAs caused
by the A10Smutation likely leave the tRNAsmore exposed
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to degradation, thereby lowering the steady-state level of
those tRNAs. Indeed, decreases of 50% and ∼25% in the
steady-state levels of tRNALys and tRNAGlu, respectively, in
those mutant cells is signiﬁcantly correlated with the de-
gree of decreases in the 2-thiouridylation between tRNALys
and tRNAGlu. Furthermore, the steady-state levels of mt
tRNALeu(UUR), tRNASer(UCN), tRNAMet, and tRNAHis were also
decreased signiﬁcantly in cells carrying both the homo-
zygous A10S and A1555G mutations. In fact, modiﬁca-
tions other than the 2-thio modiﬁcation occur in thewob-
ble position of those mt tRNAs, such as 5-taurinomethy-
luridine40 in the tRNALeu(UUR) and 5-formylcytidine41 in the
tRNAMet. Thus, the decreased TRMU activity caused by the
A10S mutation likely leads to transcriptional/translational
defects and thereby reduces the steady-state levels of those
tRNAs. Alternatively, these unmodiﬁed tRNAs may not
function accurately with the altered mitochondrial ribo-
somes carrying the A1555G mutation and especially affect
the efﬁciency and accuracy of codon-anticodon interac-
tion. As a result, the mutated TRMU, by functionally inter-
acting with the decoding region of small rRNA, particu-
larly in the site of the A1555G mutation, affects the trans-
lational efﬁciency and accuracy of codon-anticodon base
pairings in the mitochondrial ribosomes, thereby leading
to the impairment in mitochondrial-protein synthesis. In
fact, it has been suggested that the wobble modiﬁcation
defect is the primary factor for dispossessing the mutant
tRNALys of its cognate codon–binding afﬁnity, forcing the
mutant tRNALys(UUU) to become translationally inactive,
which subsequently results in mitochondrial dysfunc-
tion.42 Thus, a failure in tRNA metabolism, caused by mu-
tated TRMU, most probably leads to a reduction in the
overall rate of mitochondrial translation but is not sufﬁ-
cient to produce a clinical phenotype, as in the case of
the yeast mto2 mutant strains.17
The A1555G and the C1494T mutations locate at the
aminoacyl-tRNA decoding site (A site) of the mitochon-
drial ribosome where the codon-anticodon interactionoc-
curs43,44 and aminoglycoside antibiotics interact.45–47 These
nucleotides are adjacent to the A-site tRNA-binding bases,
includingA1408, A1492, andA1493of bacterial 16S rRNA.48
Therefore, the A1555G or the C1494Tmutationmay result
in a local conformational change in the A-site of 12S rRNA,
thereby affecting the efﬁciency and accuracy ofmitochon-
drial translation. Hypermodiﬁed tRNAs, synthesized by
the participation of TRMU, MTO1, and GTPBP3, are less
efﬁcient for the decoding of the codon ending in G than
of the codon ending in A of small rRNA.17,49 Indeed, the
A1555G or the C1494T mutation produces an ∼30% or
an ∼40% decrease in the rate of mitochondrial translation,
respectively.9,10,50 However, an ∼50% decrease in the rate
of mitochondrial translation responsible for signiﬁcant
respiratory defects was proposed as the threshold level
that produces the deafness phenotype associated with the
A1555G or the C1494T mutation.9,50 Furthermore, the
new G-C or U-A base-pairing, created by the A1555G or
the C1494T mutation, in the A site of 12S rRNA facilitates
the binding of aminoglycosides,47,51 thus causing sensitiv-
ity to those drugs.3,8,911,50 The exposure to aminoglycosides
yielded an additional 30% decrease in the rate of mito-
chondrial-protein synthesis in cells carrying the A1555G
mutation.11 In fact, aminoglycosides are concentrated in
the perilymph and endolymph of the inner ear but are
rapidly cleared in other tissues or organs.52 Therefore, a
50%–60% decrease in the rate of mitochondrial transla-
tion, caused by the combination of the A1555G mutation
with aminoglycosides, leads to cell dysfunction or death
of the auditory system, thereby inducing or worsening
hearing loss.
Unmodiﬁed tRNAs, caused by the TRMU A10S muta-
tion, may be much less efﬁcient in binding to the A-site
nucleotides of mitochondrial ribosome,53 thus leading to
a defect in translation, as in the case of E. coli tRNALys(UUU).
Those unmodiﬁed tRNA caused by the A10Smutationmay
interact very faultily with mitochondrial ribosomes car-
rying the A1555G or the C1494T mutation, thereby wors-
ening defects inmitochondrial translation associatedwith
the A1555G or the C1494T mutation. In S. cerevisiae, the
15S rRNA C1409G mutation, in conjunction with the
mto2 mutation, led to nearly complete loss of mitochon-
drial-protein synthesis.17 Here, a failure in tRNA metabo-
lism, caused by the homozygous TRMU A10S mutation,
accounted for a 120% decrease in the rate of mitochon-
drial-protein synthesis. Indeed, the ∼50% decrease in the
rate of mitochondrial translation observed in cells derived
from symptomatic individuals V-1 and V-3 of the Arab-
Israeli family was the consequence of a faulty interaction
between unmodiﬁed tRNAs caused by the TRMU A10Smu-
tation and mitochondrial ribosomes carrying the 12S rRNA
A1555Gmutation. Defects in themitochondrial translation
consequently led to a respiratory phenotype and a decline
in ATP production below the threshold level required for
normal cell function in the auditoryorgans, includingcoch-
lea, thus producing the deafness phenotype.
In summary, our study has identiﬁed the nuclear-mod-
iﬁer gene TRMU for the phenotypic expression of deafness-
associated mitochondrial 12S rRNA mutations. A point
mutation (A10S) in TRMU results in the defect in 2-thio
modiﬁcation in mt tRNAs, which leads to decreases of the
steady-state level of mt tRNAs, subsequently causing the
impairment of mitochondrial translation. Resultant bio-
chemical defects aggravate themitochondrial dysfunction
below the threshold for normal cell function, thereby ex-
pressing the deafness phenotype. Therefore, the mutated
TRMU acts in synergy with the 12S rRNA A1555G muta-
tion, modulating the phenotypic manifestation.
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